Enhanced tetracycline removal from complex real wastewater using a sustainable hog plum-ZnO-Ag2O composite
Abstract
The increasing occurrence of pharmaceutical contaminants such as tetracycline (TC) in aquatic environments poses significant environmental and public health concerns due to their persistence and contribution to antibiotic resistance. In this study, a ZnO/Ag2O-functionalized hog plum (Spondias mombin) composite (MHGP) was synthesized and evaluated for TC removal from aqueous systems. To the best of our knowledge, this represents the first report on the simultaneous ZnO and Ag2O nanoparticle modification of Spondias mombin biomass for antibiotic adsorption and its application in a real wastewater matrix. The successful incorporation of the ZnO and Ag2O nanoparticles onto the hog plum biomass (HGP) was confirmed using multiple physicochemical characterization techniques. Batch adsorption studies revealed that optimum TC removal occurred at pH 2, with an adsorbent dosage of 50 mg achieving maximum TC sequestration from a 25 mg L-1 solution within 4 h. The maximum adsorption capacity (Q max) in ultrapure water was 1.96 mg g-1. Isotherm studies showed that the Brouers-Sotolongo model best described the adsorption in ultrapure water, whereas the Sips isotherms provided a superior fit for real wastewater, indicating heterogeneous adsorption in the presence of competing ions. Kinetic modelling showed that the adsorption followed the pseudo-second-order, suggesting that adsorption may be governed by interactions involving surface functional groups and metal active sites. Despite the…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.